Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acura Pharmaceuticals Inc (ACUR)

Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 663
  • Shares Outstanding, K 66,349
  • Annual Sales, $ 1,560 K
  • Annual Income, $ -880 K
  • 60-Month Beta 1.89
  • Price/Sales 0.43
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ACUR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 01/02/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0023 +334.78%
on 04/03/24
0.0500 -80.00%
on 04/16/24
+0.0065 (+185.71%)
since 03/19/24
3-Month
0.0010 +900.00%
on 02/26/24
0.0500 -80.00%
on 04/16/24
+0.0089 (+809.09%)
since 01/16/24
52-Week
0.0001 +9,900.00%
on 12/29/23
0.0500 -80.00%
on 04/16/24
-0.0400 (-80.00%)
since 04/17/23

Most Recent Stories

More News
Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03

Amendment Extends NDA Acceptance Date...

ACUR : 0.0100 (+257.14%)
Acura Pharmaceuticals Provides Development Update on LTX-03

PALATINE, Ill., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced that the LTX-03 (hydrocodone bitartrate and...

ACUR : 0.0100 (+257.14%)
Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results

PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research,...

ACUR : 0.0100 (+257.14%)
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results

PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies...

ACUR : 0.0100 (+257.14%)
Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03

Amendment Extends NDA Acceptance Date

ACUR : 0.0100 (+257.14%)
Acura Pharmaceuticals Announces Conversion of Debt

PALATINE, Ill., June 14, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced that Abuse Deterrent Pharma, LLC (“AD Pharma”) has converted the entire principle and accrued...

ACUR : 0.0100 (+257.14%)
Acura Pharmaceuticals Provides Development Update on LTX-03

PALATINE, Ill., June 07, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced the successful completion of three NDA required registration batches of the to-be-marketed...

ACUR : 0.0100 (+257.14%)
Acura Pharmaceuticals Announces First Quarter Ended March 31, 2021 Financial Results

PALATINE, Ill., May 17, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies...

ACUR : 0.0100 (+257.14%)
Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results

PALATINE, Ill., March 31, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies...

ACUR : 0.0100 (+257.14%)
Acura Pharmaceuticals Announces Third Quarter 2020 Financial Results

PALATINE, Ill., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of technologies...

ACUR : 0.0100 (+257.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label...

See More

Key Turning Points

3rd Resistance Point 0.0117
2nd Resistance Point 0.0113
1st Resistance Point 0.0107
Last Price 0.0100
1st Support Level 0.0097
2nd Support Level 0.0093
3rd Support Level 0.0087

See More

52-Week High 0.0500
Fibonacci 61.8% 0.0309
Fibonacci 50% 0.0251
Fibonacci 38.2% 0.0192
Last Price 0.0100
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar